ReviewOncotarget2017
Antiangiogenic agents after first line and sorafenib plus chemoembolization: a systematic review.
Andrea Casadei Gardini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ReviewOncotarget2017
Andrea Casadei Gardini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.